|
|
Evaluation of 0.1% Tacrolimus eye drops in the treatment of dry eye patients caused by chronic graft-versus-host disease |
Xuyuan Tang, Jianhua Xia, Qin Wu, Chixin Du |
The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China |
|
|
Abstract Objective: To evaluate the efficacy of 0.1% Tacrolimus eye drops in the treatment of dry eye (DE) caused by chronic graft-versus-host disease (cGVHD-DE) and compare it with the treatment of lubricating eye drops. Methods: Prospective clinical study. The chronic graft-versus-host disease (cGVHD) patients with DE from The First Affiliated Hospital, Zhejiang University were included according to the inclusion criteria and categorized randomly into two different groups, Tacrolimus group (TAC) and sodium hyaluronate group (SH). Data were collected at the baseline, 2 weeks and 2 months after the treatments on patients' age, gender, primary diagnosis, time of onset, visual acuity (VA), ocular surface disease index (OSDI), corneal fluorescein staining (FL) and Schirm Ⅰ test (SⅠt). Other four objective DE indicators, including the height of tear meniscus (TMH), the first non-invasive tear break-up time (NIBUTf), the degree of conjunctival injection and the infrared meibography were also obtained and recorded by Keratograph 5M. Results: A total of 21 patients with 42 eyes were included, 11 patients (22 eyes) in the Tacrolimus group (TAC), 10 patients (20 eyes) in sodium hyaluronate group (SH). There was no significant difference in age,
gender, and all clinical indicators at the baseline between the two groups. 2 weeks after the treatments, in TAC group, OSDI score (t=3.987, P=0.0026), NIBUTf in both eyes (right eye: t=2.298, P=0.0444;left eye: t=2.415, P=0.0364) and FL in both eyes (right eye: P=0.0313, left eye: P=0.0313) were significantly improved when compared with the baseline, in SH group, the indicators were OSDI score (t=3.200, P=0.0108) and NIBUTf in right eyes (t=2.462, P=0.036) that had significant improvement. After 2 months of treatment, all clinical dry eye indicators in the TAC group were significantly improved compared with the baseline (P<0.001). But in the SH group, the (SⅠt) and the infrared meibography had no statistically significant difference when compared with the baseline. Comparing the two groups after 2 months of treatment, we found that all indicators in the TAC group were more significantly improved than that in the SH group, except for the FL, in which the difference had no statistical significance (P<0.05). No adverse ocular effect was found in the study in both groups. Conclusions: 0.1% tacrolimus eye drops are safe and effective in the treatment of cGVHD-DE, and Keratograph 5M is helpful in the evaluation and follow-up of the treatments.
|
Received: 22 December 2019
|
Fund: Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (No.2017198589) |
Corresponding Authors:
Chixin Du, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China
(Email: duchixin@zju.edu.cn)
|
|
|
|
[1] |
Pidala J, Anasetti C, Jim H. Quality of life after allogeneic
|
|
hematopoietic cell transplantation. Blood, 2009, 114(1): 7-19.
|
|
DOI: 10.1182/blood-2008-10-182592.
|
[2] |
Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after
|
|
allogeneic hematopoietic-cell transplantation. N Engl J Med,
|
20 |
10, 363(22): 2091-2101. DOI:10.1056/NEJMoa1004383.
|
[3] |
Flowers ME, Parker PM, Johnston LJ, et al. Comparison
|
|
of chronic graft-versus-host disease after transplantation of
|
|
peripheral blood stem cells versus bone marrow in allogeneic
|
|
recipients: long-term follow-up of a randomized trial. Blood,
|
20 |
02, 100(2): 415-419. DOI: 10.1182/blood-2002-01-0011.
|
[4] |
Copelan EA. Hematopoietic stem-cell transplantation. N Engl J
|
|
Med, 2006, 354(17): 1813-1826. DOI:10.1056/NEJMra052638.
|
[5] |
Higman MA, Vogelsang GB. Chronic graft versus host disease.
|
|
Br J Haematol, 2004, 125(4): 435-454. DOI: 10.1111/j.1365-
|
21 |
41.2004.04945.x.
|
[6] |
Ji WJ, Lee YJ, Sang CY, et al. Long-term Result of Maintenance
|
|
Treatment With Tacrolimus Ointment in Chronic Ocular GraftVersus-Host Disease. Am J Ophthalmol, 2015, 159(3): 519-527.
|
|
DOI: 10.1016/j.ajo.2014.11.035.
|
[7] |
Sanz-Marco E, Udaondo P, García-Delpech S, et al. Treatment
|
|
of refractory dry eye associated with graft versus host disease
|
|
with 0.03% tacrolimus eyedrops. J Ocul Pharmacol Ther, 2013,
|
29 |
(8): 776-83. DOI: 10.1089/jop.2012.0265.[8] Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel
|
|
immunosuppressant isolated from a Streptomyces. II.
|
|
Immunosuppressive effect of FK-506 in vitro. J Antibiot
|
|
(Tokyo), 1987, 40(9): 1256-1265. DOI: 10.7164/
|
|
antibiotics.40.1256.
|
[9] |
Muduma G, Saunders R, Odeyemi I, et a1. Systematic review
|
|
and Meta-analysis of tacrelimus versus ciclosporin as primary
|
|
immuno suppression after liver transplant. PLoS One, 2016,
|
11 |
(11): e160421. DOI: 10.1371/journal.pone.0160421.
|
[10] |
蒋冲, 邓俐, 陈飚, 等. 长期外用他克莫司软膏对特应性皮炎
|
|
患者免疫力的影响. 皮肤性病诊疗学杂志, 2013, 20(2): 93-96.
|
|
DOI: 10.3969/j.issn.1674-8468.2013.02.007.
|
[11] |
中华医学会眼科学分会角膜病学组. 干眼临床诊疗专家共识
|
|
(2013年). 中华眼科杂志, 2013, 49(1): 73. DOI: 10.3760/cma.
|
|
j.issn.0412-4081.2013.01.020.
|
[12] |
Smith JA. The epidemiology of dry eye disease: report of the
|
|
Epidemiology Subcommittee of the International Dry Eye
|
|
WorkShop (2007). Ocul Surf, 2007, 5(2): 93-107. DOI: 10.1016/
|
|
s1542-0124(12)70082-4.
|
[13] |
Bron AJ, Evans VE, Smith JA. Grading of corneal and
|
|
conjunctival staining in the context of other dry eye tests. Cornea,
|
20 |
03, 22(7): 640-50. DOI: 10.1097/00003226-200310000-00008.
|
[14] |
Aoki S, Mizote H, Minamoto A, et al. Systemic FK506
|
|
improved tear secretion in dry eye associated with chronic graft
|
|
versus host disease. Br J Ophthalmol, 2005, 89(2): 243-244.
|
|
DOI: 10.1136/bjo.2004.051391.
|
[15] |
闫应朝, 李锦阳, 陈梦曦, 等. 他克莫司治疗碱烧伤致大鼠
|
|
非特异性角膜炎的疗效及安全性. 中华眼视光学与视觉科
|
|
学杂志, 2016, 18(1): 33-40. DOI: 10.3760/cma.j.issn.1674-
|
84 |
5X.2016.01.008.
|
[16] |
王海英, 姚向超, 苏映雪, 等. 他克莫司滴眼液对小鼠结膜干
|
|
燥综合征的疗效观察. 今日药学, 2015, (11): 748-752.
|
[17] |
Moscovici BK, Holzchuh R, Sakassegawanaves FE, et
|
|
al. Treatment of Sj?gren's syndrome dry eye using 0.03%
|
|
tacrolimus eye drop: Prospective double-blind randomized
|
|
study. Cont Lens Anterior Eye, 2015, 38(5): 373-378. DOI:
|
10 |
1016/j.clae.2015.04.004.
|
[18] |
Sanz-Marco E, Udaondo P, García-Delpech S, et al. Treatment
|
|
of Refractory Dry Eye Associated with Graft Versus Host
|
|
Disease with 0.03% Tacrolimus Eyedrops. J Ocul Pharmacol
|
|
Ther, 2013, 29 (8): 776-783. DOI: 10.1089/jop.2012.0265.
|
[19] |
费文雷, 陈家祺, 杜欣, 等. 移植物抗宿主病相关的干眼病.
|
|
中华眼科杂志, 2003, 39(11): 686-690. DOI: 10.3760/j.issn.
|
04 |
12-4081.2003.11.011.
|
|
|
|